Hepatic gene transfer of the catalytic subunit of the apolipoprotein B mRNA editing enzyme results in a reduction of plasma LDL levels in normal and Watanabe heritable hyperlipidemic rabbits

Journal of Lipid Research

Volumn 37, Issue 9, 1996, Pages 2001-2017

  Greeve, Jobst ^a   Jona, Vinod K ^b   Roy Chowdhury, Namita ^b   Horwitz, Marshall S ^b   Roy Chowdhury, Jayanta ^b  

^a UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

^b ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

Author keywords

adenovirus mediated gene transfer; apoB mRNA editing; apoB mRNA editing catalytic polypeptide 1; atherosclerosis

Indexed keywords

APOLIPOPROTEIN B; APOLIPOPROTEIN B100; APOLIPOPROTEIN B48; APOLIPOPROTEIN E; BETA GALACTOSIDASE; ENZYME; LOW DENSITY LIPOPROTEIN; MESSENGER RNA; VERY LOW DENSITY LIPOPROTEIN;

ADENOVIRUS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; ENZYME ACTIVE SITE; FAMILIAL HYPERLIPEMIA; GENE TRANSFER; HUMAN; HUMAN CELL; LIPID COMPOSITION; MALE; NONHUMAN; PARTICLE SIZE; PRIORITY JOURNAL; RABBIT; RNA EDITING; VIRUS RECOMBINANT;

ADENOVIRIDAE; ANIMALS; APOLIPOPROTEIN B-100; APOLIPOPROTEINS B; CHOLESTEROL, HDL; CHOLESTEROL, LDL; CHOLESTEROL, VLDL; CYTIDINE DEAMINASE; FASTING; GENE TRANSFER TECHNIQUES; HYPERLIPIDEMIAS; LIPOPROTEINS, LDL; LIPOPROTEINS, VLDL; LIVER; MALE; RABBITS; RATS; RNA EDITING; TRIGLYCERIDES;

EID: 0029794714     PISSN: 00222275     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (46)

1. Kane, J. P. 1983. Apolipoprotein B: structural and metabolic heterogeneity. Annu. Rev. Physiol. 45: 637-650.
2. Goldstein, J. L., and M. S. Brown. 1986. A receptor-mediated pathway for cholesterol homeostasis. Science. 232: 34-47.
3. Steinberg, D., and J. L. Witztum. 1990. Lipoproteins and atherosclerosis. Current concepts. J. Am. Med. Assoc. 64: 3047-3052.
4. Scanu, A. M., and G. M. Fless. 1990. Lipoprotein [a]. Heterogeneity and biological relevance. J. Clin. Invest. 85: 1709-1715.
5. Powell, L. M., S. C. Wallis, R. J. Pease, Y. H. Edwards, T. J. Knott, and J. Scott. 1987. A novel form of tissue-specific RNA processing produces apoB-48 in the intestine. Cell. 50: 831-840.
6. Chen, S. H., G. Habib, C. Y. Yang, Z. W. Gu, B. R. Lee, S. A. Weng, S. R. Silbermann, S. J. Cai, J. P. Deslypere, M. Rosseneu, A. M. Gotto, W. H. Li, and L. Chan. 1987. ApoB-48 is the product from a messenger RNA with an organ-specific in-frame translational stop codon. Science. 238: 363-366.
7. Greeve, J., N. Navaratnam, and J. Scott. 1991. Characterisation of the apolipoprotein B mRNA editing enzyme: no similarity to the proposed mechanism of RNA editing in kinetoplastid protozoa. Nucleic Acids Res. 19: 3569-3576.
8. Hodges, P., N. Navaratnam, J. Greeve, and J. Scott. 1991. Site-specific creation of uridine from cytidine in apolipoprotein B mRNA. Nucleic Acids Res. 19: 1197-1201.
9. Lau, P. P., W. Xiong, H. J. Zhu, S. H. Chen, and L. Chan. 1991. Apolipoprotein B mRNA editing is an intranuclear event that occurs posttranslationally coincident with splicing and polyadenylation. J. Biol. Chem. 266: 20550-20554.
10. Harris, S. G., I. Sabio, E. Mayer, M. F. Steinberg, J. W. Backus, J. D. Sparks, C. E. Sparks, and H. C. Smith. 1993. Extract-specific heterogeneity in higher-order complexes containing apolipoprotein B mRNA editing activity and RNA-binding proteins. J. Biol. Chem. 268: 7382-7392.
11. Shah, R. R., T. J. Knott, J. E. LeGros, N. Navaratnam, J. Greeve, and J. Scott. 1991. Sequence requirements for editing of apolipoprotein B mRNA. J. Biol. Chem. 266: 16301-16304.
12. Teng, B. B., C. F. Burand, and N. O. Davidson. 1993. Molecular cloning of an apolipoprotein B messenger RNA editing protein. Science. 260: 1816-1819.
13. Navaratnam, N., J. R. Morrison, S. Battacharya, D. Patel, T. Funahashi, F. Giannoni, B. B. Teng, N. O. Davidson, and J. Scott. 1993. The p27 catalytic subunit of the apolipoprotein B mRNA editing enzyme is a cytidine deaminase. J. Biol. Chem. 268: 20709-20712.
14. Driscoll, D. M., and Q. Zhang. 1994. Expression and characterisation of p27, the catalytic subunit of the apolipoprotein B mRNA editing enzyme. J. Biol. Chem. 269: 19843-19847.
15. Yamanaka, S., K. S. Poksay, M. E. Balestra, G. Q. Zeng, and T. L. Innerarity. 1994. Cloning and mutagenesis of the rabbit apoB mRNA editing protein. J. Biol. Chem. 269: 21725-21734.
16. Lau, P. P., H. J. Zhu, A. Baldini, C. Charnsangavei, and L. Chan. 1994. Dimeric structure of a human apolipoprotein B mRNA editing protein and cloning and chromosomal localisation of its gene. Proc. Natl. Acad. Sci. USA. 91: 8522-8526.
17. Navaratnam, N., S. Bhattacharya, T. Fufino, D. Patel, A. L. Jaumuz, and J. Scott. 1995. Evolutionary origins of apoB mRNA editing: catalysis by a cytidine deaminase that has aquired a novel RNA-binding motif at its active site. Cell. 81: 187-195.
18. Scott, J., N. Navaratnam, S. Bhattacharya, and J. R. Morrison. 1994. The apolipoprotein messenger RNA editing enzyme. Curr. Opin. Lipidol. 5: 87-93.
19. Schock, D., S-R. Kuo, M. F. Steinburg, M. Bolognino, J. D. Sparks, C. E. Sparks, and H. C. Smith. 1996. An auxilliary factor containing a 240 kDa protein complex is involved in apolipoprotein B mRNA editing. Proc. Natl. Acad. Sci. USA. 93: 1097-1102.
20. Greeve, J., I. Altkemper, J-H. Dieterich, H. Greten, and E. Windler. 1993. Apolipoprotein B mRNA editing in 12 different mammalian species: hepatic expression is reflected in low concentrations of apoB-containing plasma lipoproteins. J. Lipid Res. 34: 1367-1382.
21. Hardtmann, D. A., C. R. Pullinger, R. L. Hamilton, J. P. Kane, and M. J. Malloy. 1991. Molecular and metabolic basis for the metabolic disorder normotriglyceridemic abetalipoproteinemia. J. Clin. Invest. 88: 1722-1729.
22. Giannoni, F., D. K. Bonen, T. Funahashi, C. Hadjiagapiou, C. F. Burant, and N. O. Davidson. 1994. Complementation of apolipoprotein B mRNA editing by human liver accompanied by secretion of apolipoprotein B-48. J. Biol. Chem. 269: 5932-5936.
23. Yamanaka, S., M. E. Balestra, L. D. Ferrell, J. Fan, K. S. Arnold, S. Taylor, J. M. Taylor, and T. L. Innerarity. 1995. Apolipoprotein B mRNA editing protein induces hepatocellular carcinoma and dysplasia in transgenic animals. Proc. Natl. Acad. Sci. USA. 92: 8483-8487.
24. McGrory, W. J., D. A. Bautista, and F. L. Graham. 1988. A simple technique for the rescue of early region I mutations into infectious human adenovirus type 5. Virology. 163: 614-617.
25. Herz, J., and R. D. Gerard. 1993. Adenovirus-mediated transfer of low density lipoprotein receptor gene acutely accelerates cholesterol clearance in normal mice. Proc. Natl. Acad. Sci. USA. 90: 2812-2816.
26. Zhang, W. W., X. Fang, C. D. Branch, W. Mazur, B. A. French, and J. A. Roth. 1993. Generation and identification of recombinant adenovirus by liposome-mediated transfection and PCR analysis. Biotechniques. 15: 868-872.
27. Horwitz, M. S. 1976. Bidirectional replication of adenovirus type 2 DNA. J. Virol. 18: 307-315.
28. Horwitz, M. S. 1971. Intermediates in the synthesis of type 2 adenovirus deoxyribonucleic acids. J. Virol. 8: 675-683.
29. Roy Chowdhury, J., M. Grossman, S. Gupta, N. Roy Chowdhury, J. R. Baker, and J. M. Wilson. 1991. Long term improvement of hypercholesterolemia after ex vivo gene therapy in LDL-receptor-deficient rabbits. Science. 254: 1802-1805.
30. Wilson, J. M., M. Grossman, C. H. Wu, N. Roy Chowdhury, G. Y. Wu, and J. Roy Chowdhury. 1992. Hepatocyte-directed gene transfer in vivo leads to transient improvement in low density lipoprotein receptor-deficient rabbits. J. Biol. Chem. 267: 963-967.
31. Windler, E., J. Greeve, W. Daerr, and H. Greten. 1988. Binding of rat chylomicrons and their remnants to the hepatic low density lipoprotein receptor and its role in remnant removal. Biochem. J. 252: 553-561.
32. Forte, T. M., and R. W. Nordhausen. 1986. Electron microscopy of negatively stained lipoproteins. Methods Enzymol. 128: 442-457.
33. Watanabe, Y. 1980. Serial inbreeding of rabbits with hereditary hyperlipidemia (WHHL rabbit): incidence and development of atherosclerosis and xanthoma. Atherosclerosis. 6: 261-268.
34. Yamamoto, T., R. W. Bishop, M. S. Brown, J. L. Goldstein, and D. W. Russel. 1986. Deletion in the cysteine-rich region of LDL-receptors impedes transport to cell surface in WHHL rabbits. Science. 232: 1230-1235.
35. Teng, B. B., S. Blumenthal, T. Forte, N. Navaratnam, J. Scott, A. M. Gotto, and L. Chan. 1994. Adenovirus-mediated gene transfer of rat apolipoprotein B mRNA editing protein in mice virtually eliminates apolipoprotein B-100 and normal low density lipoprotein production. J. Biol. Chem. 269: 29395-29404.
36. Li, X., F. Catalina, S. M. Grundy, and S. Patel. 1996. Method to measure apolipoprotein B-48 and B-100 secretion rates in an individual mouse: evidence for a very rapid turn-over of VLDL and preferential removal of B-48-relative to B-100-containing lipoproteins. J. Lipid Res. 37: 210-220.
37. Mahmood Hussain, M., Y. Zhao, R. K. Kancha, B. D. Blackhart, and Z. Yao. 1995. Characterisation of recombinant human apoB-48-containing lipoproteins in rat hepatoma McA-RH7777 cells transfected with apoB-48 cDNA. Arterioscler. Thromb. 15: 485-494.
38. Heinemann, T. S., E. A. Metzger, T. J. Fisher, J. L. Breslow, and L. S. Huang. 1994. Alternative polyadenylation of apolipoprotein B RNA is a major cause for B-48 protein formation in rat hepatoma cell lines transfected with human apoB minigenes. J. Lipid Res. 35: 2200-2211.
39. Kozarsky, K. F., D. R. McKinley, L. A. Austin, S. Raper, L. D. Stratford-Perricaudet, and J. M. Wilson. 1994. In vivo correction of low density lipoprotein receptor deficiency in the Watanabe heritable hyperlipidemic rabbit with recombinant adenoviruses. J. Biol. Chem. 269: 13695-13702.
40. Li, J. B., B. Fang, R. C. Eisensmith, X. H. C. Li, I. Nasonkin, Y. C. Lin-Lee, M. M. Mims, A. Hughes, C. D. Montgomery, J. D. Roberts, T. S. Parker, D. M. Levine, and S. L. C. Woo. 1995. In vivo gene therapy for hyperlipidemia: phenotypic correction in Watanabe rabbits by hepatic delivery of the rabbit LDL-receptor gene. J. Clin. Invest. 95: 768-773.
41. Nagata, Y., Y. J. Chen, and A. D. Cooper. 1988. Role of low density lipoprotein receptor-dependent and -independent sites in binding and uptake of chylomicron remnants in rat liver. J. Biol. Chem. 263: 15151-15158.
42. Choi, S. Y., and A. D. Cooper. 1993. A comparison of the roles of the low density lipoprotein (LDL) receptor and the LDL receptor-related protein/α2-macroglobulin receptor in chylomicron removal in the mouse in vivo. J. Biol. Chem. 268: 15804-15811.
43. Vega, G. L., K. von Bergmann, S. M. Grundy, W. Beltz, C. Jahn, and C. East. 1987. Increased catabolism of VLDL-apolipoprotein B and synthesis of bile-acids in a case of hypobetalipoproteinemia. Metabolism. 36: 262-269.
44. Parhofer, K. D., A. Daugherty, M. Kinoshita, and G. Schonfeld. 1990. Enhanced clearance from plasma of low density lipoproteins containing a truncated apolipoprotein, apoB-89. J. Lipid Res. 31: 2001-2007.
45. Aguilar-Salinas, C. A., P. H. Barrett, K. G. Parhofer, S. G. Young, D. Tesserau, J. Bateman, C. Quinn, and G. Schonfeld. 1995. Apoprotein B-100 production is decreased in subjects heterozygous for truncations of apoprotein B. Arterioscler. Thromb. 15: 71-80.
46. Chang, A. G. Y., and G. Y. Wu. 1994. Gene therapy: application to the treatment of gastrointestinal and liver diseases. Gastroenterology. 106: 1076-1084.